Lumos Pharma Inc (LUMO)
4.33
+0.01
(+0.23%)
USD |
NASDAQ |
Nov 21, 16:00
4.33
0.00 (0.00%)
After-Hours: 20:00
Lumos Pharma Price: 4.33 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 4.33 | 4.34 | 4.32 | 4.32 | 83005.00 |
| Nov 19, 2024 | 4.32 | 4.35 | 4.32 | 4.33 | 95885.00 |
| Nov 18, 2024 | 4.32 | 4.35 | 4.32 | 4.32 | 74237.00 |
| Nov 15, 2024 | 4.340 | 4.39 | 4.30 | 4.33 | 101610.0 |
| Nov 14, 2024 | 4.31 | 4.34 | 4.31 | 4.33 | 22724.00 |
| Nov 13, 2024 | 4.31 | 4.44 | 4.28 | 4.30 | 96582.00 |
| Nov 12, 2024 | 4.41 | 4.41 | 4.25 | 4.36 | 141303.0 |
| Nov 11, 2024 | 4.32 | 4.42 | 4.30 | 4.37 | 166756.0 |
| Nov 08, 2024 | 4.31 | 4.42 | 4.31 | 4.359 | 52866.00 |
| Nov 07, 2024 | 4.31 | 4.405 | 4.31 | 4.325 | 69085.00 |
| Nov 06, 2024 | 4.40 | 4.40 | 4.31 | 4.31 | 56217.00 |
| Nov 05, 2024 | 4.45 | 4.45 | 4.360 | 4.39 | 9465.00 |
| Nov 04, 2024 | 4.40 | 4.467 | 4.370 | 4.415 | 43837.00 |
| Nov 01, 2024 | 4.42 | 4.49 | 4.36 | 4.37 | 18594.00 |
| Oct 31, 2024 | 4.32 | 4.45 | 4.30 | 4.44 | 94843.00 |
| Oct 30, 2024 | 4.37 | 4.45 | 4.31 | 4.34 | 78853.00 |
| Oct 29, 2024 | 4.48 | 4.48 | 4.366 | 4.37 | 12120.00 |
| Oct 28, 2024 | 4.38 | 4.48 | 4.33 | 4.45 | 110220.0 |
| Oct 25, 2024 | 4.34 | 4.46 | 4.31 | 4.40 | 135120.0 |
| Oct 24, 2024 | 4.42 | 4.43 | 4.30 | 4.35 | 438051.0 |
| Oct 23, 2024 | 4.41 | 4.576 | 4.33 | 4.36 | 917799.0 |
| Oct 22, 2024 | 3.94 | 4.36 | 3.92 | 3.95 | 43567.00 |
| Oct 21, 2024 | 3.98 | 4.038 | 3.730 | 3.730 | 6529.00 |
| Oct 18, 2024 | 3.610 | 4.04 | 3.610 | 4.02 | 15631.00 |
| Oct 17, 2024 | 3.91 | 4.00 | 3.78 | 3.78 | 4882.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.45
Minimum
Jul 18 2024
35.91
Maximum
Dec 30 2020
8.333
Average
7.985
Median
Price Benchmarks
| Boston Scientific Corp | 91.50 |
| Calidi Biotherapeutics Inc | 2.155 |
| NovaBay Pharmaceuticals Inc | 0.718 |
| Palatin Technologies Inc | 0.91 |
| iBio Inc | 2.45 |
Price Related Metrics
| PS Ratio | 16.02 |
| PEG Ratio | -0.1392 |
| Price to Book Value | 7.621 |
| Earnings Yield | -99.08% |
| Market Cap | 37.45M |
| PEGY Ratio | -0.1392 |